An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

Artificial intelligence (AI) is fundamentally reshaping the landscape of solid tumor (ST) drug development. By integrating multi-omics data, spatial ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Prediction of crystal structures of organic molecules is a critical task in many industries, especially in pharmaceuticals ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

Crystal structure prediction (CSP) of organic molecules is a critical task, especially in pharmaceuticals and materials ...

The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to accelerate life science research by driving development and adoption of virtual cell models through tools, ...